Loading: 100%
BIOMARIN PHARMACEUTICAL INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 2,293 (as per Q1 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker BMRNno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1780859095100
datesClosing price (adj.)
13.10.201795.12
11.10.201794.93
04.10.201793.20
27.09.201792.71
20.09.201792.57
13.09.201792.75
06.09.201789.84
30.08.201787.65
23.08.201781.40
16.08.201783.07
09.08.201785.16
02.08.201787.64
26.07.201789.20
19.07.201787.23
12.07.201789.57
05.07.201792.01
27.06.201789.63
20.06.201792.36
13.06.201790.39
06.06.201789.58
30.05.201787.88
23.05.201788.36
16.05.201792.45
09.05.201791.16
02.05.201795.93
25.04.201794.19
18.04.201790.95
11.04.201788.53
04.04.201786.03
28.03.201789.10
21.03.201787.03
14.03.201791.65
07.03.201789.23
28.02.201793.93
21.02.201790.24
14.02.201791.19
07.02.201788.91
31.01.201787.63
24.01.201784.34
17.01.201785.21
10.01.201790.40
03.01.201785.84
27.12.201685.08
19.12.201684.38
12.12.201682.01
05.12.201682.45
28.11.201688.36
21.11.201687.50
14.11.201692.91
07.11.201683.54
31.10.201680.52
24.10.201682.14
17.10.201685.45
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
95.12n/a
Market Capitalisation
in million USD
16,597n/a
Enterprise Value
in million USD
16,764n/a
Common Shares Outstanding
as per Apr 20, 2017
174,490,025n/a
Preferred Shares Outstanding
as per Apr 20, 2017
n/a
Average Basic Shares Outstanding
TTM
168,775,500n/a
Average Diluted Shares Outstanding
TTM
166,219,000n/a
Index Membership
n/a
Business Summary
Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 974n/a
Gross Profit 796n/a
Operating Income -287n/a
EBITDA -214n/a
Net Profit -531n/a
Balance Sheet
Cash and Cash Equivalents 503n/a
Receivables 214n/a
Total Current Assets 1,106n/a
PP&E 724n/a
Total Assets 3,087n/a
Accounts Payable 0n/a
Current Debt 24n/a
Total Current Liabilities 365n/a
Long-Term Debt 646n/a
Total Liabilities 1,170n/a
Total Equity 1,918n/a
Cash Flow
Depreciation & Amortisation 73n/a
Change in Working Capital -50n/a
Operating Cash Flow -288n/a
Net Change in PP&E and Intangibles 191n/a
Investing Cash Flow 169n/a
Dividends Paid 0n/a
Financing Cash Flow -14n/a
Total Change in Cash -135n/a
Free Cash Flow 65n/a
Profitability Ratios
Gross Margin 81.8%n/a
Operating Margin -29.5%n/a
Net Profit Margin -54.5%n/a
Return on Equity -27.7%n/a
Return on Assets -17.2%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA -78.32n/a
EV/Sales 17.22n/a
Book to Market Value 0.12n/a
Other Ratios
Current Ratio 303.4%n/a
Liabilities to Equity Ratio 61.0%n/a
Debt to Assets Ratio 21.7%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
296
325
376
441
501
548
749
890
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-53
-66
-70
-84
-92
-88
-122
-152
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
244
259
306
357
409
460
627
738
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-200
-239
-299
-390
-500
-590
-764
-1,037
Selling, General & Administrative
-107
-124
-152
-175
-198
-235
-302
-402
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-93
-115
-147
-214
-302
-355
-462
-635
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
44
19
7
-32
-91
-130
-137
-299
Non-Operating Income (Loss)
-2
-12
-9
-8
-8
-8
-31
-44
Interest Expense, net
0
-9
-7
-5
-5
-7
-31
-34
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
-2
-3
-3
-2
-1
-1
-1
-1
Other Non-Operating Income (Loss)
0
0
0
0
-2
1
0
-9
Pretax Income (Loss), Adjusted
42
8
-2
-40
-100
-138
-168
-343
Abnormal Gains (Losses)
-8
-7
-19
-3
-19
-39
43
188
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
33
1
-21
-44
-118
-177
-125
-155
Income Tax (Expense) Benefit, net
-3
-1
227
-10
4
0
-9
-17
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
31
0
206
-54
-114
-176
-134
-172
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
31
0
206
-54
-114
-176
-134
-172
Minority Interest
0
0
0
0
0
0
0
0
Net Income
31
0
206
-54
-114
-176
-134
-172
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
31
0
206
-54
-114
-176
-134
-172
Remarks
restated on Feb 24, 2011 n/a
calculated values,
restated on Feb 22, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 26, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
301
274
195
448
785
945
593
Cash & Cash Equivalents
n/a
167
88
46
181
569
875
397
Short Term Investments
n/a
134
186
149
267
216
70
196
Accounts & Notes Receivable
n/a
74
87
105
109
118
144
165
Accounts Receivable, Net
n/a
74
87
105
109
118
144
165
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
79
110
130
129
163
199
272
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
15
34
40
58
72
109
60
Prepaid Expenses
n/a
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
21
32
31
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
15
34
19
26
42
109
60
Total Current Assets
n/a
468
504
470
743
1,137
1,398
1,090
Property, Plant & Equipment, Net
n/a
199
222
269
284
319
524
704
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
170
128
94
116
268
98
426
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
80
408
473
424
520
456
1,510
Intangible Assets
n/a
41
104
180
163
163
157
684
Goodwill
n/a
24
53
52
52
54
54
197
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
236
225
189
145
191
220
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
1
1
1
1
0
0
Miscellaneous Long Term Assets
n/a
15
14
15
20
156
55
409
Total Noncurrent Assets
n/a
449
758
836
825
1,107
1,078
2,640
Total Assets
n/a
917
1,263
1,306
1,568
2,244
2,475
3,729
Liabilities and owners' equity
Payables & Accruals
n/a
78 78068000
84 83844000
94 94125000
147 147068000
183 183271000
232 231844000
393 392511000
Accounts Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
78 78068000
84 83844000
94 94125000
147 147068000
183 183271000
232 231844000
393 392511000
Short Term Debt
n/a
0 0
0 0
0 0
23 23365000
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 86000
0 0
0 0
0 0
0 0
4 3895000
53 52946000
Deferred Revenue
n/a
0 86000
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
4 3895000
53 52946000
Total Current Liabilities
n/a
78 78154000
84 83844000
94 94125000
170 170433000
183 183271000
236 235739000
445 445457000
Long Term Debt
n/a
497 497083000
378 377521000
348 348329000
325 324859000
656 655566000
643 642902000
662 662286000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
20 19741000
84 84001000
90 90207000
57 57292000
64 64182000
69 68844000
221 220778000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
37 37155000
0 0
0 0
0 0
144 143527000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
20 19741000
84 84001000
53 53052000
57 57292000
64 64182000
69 68844000
77 77251000
Total Noncurrent Liabilities
n/a
517 516824000
462 461522000
439 438536000
382 382151000
720 719748000
712 711746000
883 883064000
Total Liabilities
n/a
595 594978000
545 545366000
533 532661000
553 552584000
903 903019000
947 947485000
1,329 1328521000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
898 898336000
1,088 1088334000
1,193 1193262000
1,555 1555413000
2,052 2051824000
2,350 2350198000
3,401 3401383000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-577 -577084000
-371 -371265000
-425 -425101000
-539 -539448000
-716 -715801000
-850 -849770000
-1,022 -1021569000
Other Equity
n/a
1 933000
0 188000
5 4887000
0 -202000
5 5018000
27 27466000
21 21033000
Equity Before Minority Interest
n/a
322 322185000
717 717257000
773 773048000
1,016 1015763000
1,341 1341041000
1,528 1527894000
2,401 2400847000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
322 322185000
717 717257000
773 773048000
1,016 1015763000
1,341 1341041000
1,528 1527894000
2,401 2400847000
Total Liabilities & Equity
n/a
917 917163000
1,263 1262623000
1,306 1305709000
1,568 1568347000
2,244 2244060000
2,475 2475379000
3,729 3729368000
Remarks restated on n/a restated on Feb 24, 2011 n/a restated on Feb 22, 2012 n/a restated on Feb 26, 2013 n/a restated on Feb 26, 2014 n/a restated on Mar 2, 2015 n/a restated on Feb 29, 2016 n/a restated on Feb 27, 2017 n/a
Cash Flow StatementCF data quality: 97% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
31
0
206
-54
-114
-176
-134
-172
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
18
21
28
35
44
36
46
47
Non-Cash Items
31
47
-173
63
55
91
32
-143
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
-89
20
-42
-25
33
-8
-16
46
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
-9
88
19
18
18
-57
-72
-222
Change in Fixed Assets & Intangibles
-56
-90
-49
-154
-45
-65
-50
182
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
28
30
-15
67
-144
-106
301
-448
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
17
-18
-33
0
0
-10
0
-538
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
-7
-2
-4
-2
-7
-117
-55
-375
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-19
-80
-101
-90
-196
-299
196
-1,180
Dividends Paid
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-7
-74
-14
-3
0
713
-1
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
28
11
33
34
319
73
197
951
Increase in Capital Stock
28
11
33
34
319
73
197
951
Decrease in Capital Stock
0
0
0
0
0
0
0
0
Other Financing Activities
1
-1
-15
-1
-6
-39
-11
-23
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
23
-64
4
29
312
747
186
928
Net Cash Before Disc. Operations and FX
-5
-56
-79
-42
134
390
310
-473
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
-5
-56
-79
-42
134
390
310
-473
Effect of Foreign Exchange Rates
0
0
0
0
0
-2
-3
-5
Net Changes in Cash
-5
-56
-79
-42
134
388
307
-478
Remarks
restated on Feb 24, 2011 n/a
calculated values,
restated on Feb 22, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 26, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo